Inhibition_NN
of_IN
nuclear_JJ
factor_NN
kappa_NN
B_NN
subunit_NN
p65_NN
mRNA_NN
accumulation_NN
in_IN
lipopolysaccharide-stimulated_JJ
human_JJ
monocytic_JJ
cells_NNS
treated_VBN
with_IN
sodium_NN
salicylate_NN
._.

Lipopolysaccharide_NN
is_VBZ
one_CD
of_IN
the_DT
most_RBS
potent_JJ
trigger_NN
substances_NNS
for_IN
monocytes_NNS
and_CC
macrophages_NNS
causing_VBG
secretion_NN
of_IN
inflammatory_JJ
mediators_NNS
such_JJ
as_IN
tumor_NN
necrosis_NN
factor_NN
and_CC
interleukin-1_NN
._.

The_DT
nature_NN
of_IN
the_DT
nuclear_JJ
factors_NNS
involved_VBN
in_IN
regulation_NN
of_IN
these_DT
cytokine_NN
genes_NNS
is_VBZ
still_RB
unknown_JJ
._.

Nuclear_JJ
factor_NN
kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
;_:
heterodimer_NN
of_IN
p50_NN
and_CC
p65_NN
-RRB-_-RRB-
proteins_NNS
have_VBP
been_VBN
suggested_VBN
to_TO
play_VB
an_DT
important_JJ
role_NN
in_IN
gene_NN
transcription_NN
of_IN
inflammatory_JJ
mediators_NNS
when_WRB
monocytes_NNS
are_VBP
stimulated_VBN
with_IN
lipopolysaccharide_NN
._.

Nonsteroidal_JJ
anti-inflammatory_JJ
drugs_NNS
such_JJ
as_IN
salicylates_NNS
have_VBP
been_VBN
used_VBN
to_TO
treat_VB
symptoms_NNS
of_IN
inflammation_NN
,_,
and_CC
a_DT
new_JJ
mechanism_NN
of_IN
drug_NN
action_NN
was_VBD
suggested_VBN
recently_RB
._.

Salicylates_NNS
have_VBP
been_VBN
shown_VBN
to_TO
inhibit_VB
lipopolysaccharide-induced_JJ
gene_NN
transcription_NN
via_IN
inhibition_NN
of_IN
NF-kappa_NN
B_NN
activation_NN
by_IN
preventing_VBG
the_DT
degradation_NN
of_IN
NF-kappa_NN
B_NN
inhibitor_NN
``_NN
I_CD
kappa_NN
B_NN
''_NN
,_,
blocking_VBG
the_DT
translocation_NN
of_IN
NF-kappa_NN
B_NN
into_IN
the_DT
nuclear_JJ
compartment_NN
._.

However_RB
,_,
the_DT
nature_NN
of_IN
the_DT
subunit_NN
involved_VBN
in_IN
this_DT
mechanism_NN
has_VBZ
not_RB
been_VBN
defined_VBN
._.

To_TO
examine_VB
the_DT
mechanisms_NNS
by_IN
which_WDT
salicylates_NNS
affect_VBP
cytokine_NN
gene_NN
transcription_NN
,_,
the_DT
amount_NN
of_IN
active_JJ
and_CC
inactive_JJ
NF-kappa_NN
B_NN
and_CC
NF-kappa_NN
B_NN
mRNA_NN
,_,
in_IN
Porphyromonas_NN
gingivalis_NN
lipopolysaccharide-stimulated_JJ
human_JJ
monocytic_JJ
cells_NNS
was_VBD
assessed_VBN
._.

High_JJ
doses_NNS
of_IN
sodium_NN
salicylate_NN
suppressed_VBD
NF-kappa_NN
B_NN
p65_NN
mRNA_NN
accumulation_NN
,_,
resulting_VBG
in_IN
suppression_NN
of_IN
total_JJ
NF-kappa_NN
B_NN
,_,
p50_NN
on_IN
tissue_NN
oligonucleotide_NN
had_VBD
no_DT
effects_NNS
on_IN
lipopolysaccharide-induced_JJ
NF-kappa_NN
B_NN
activation_NN
._.

The_DT
data_NNS
demonstrate_VBP
that_IN
the_DT
p65_NN
subunit_NN
of_IN
NF-kappa_NN
B_NN
is_VBZ
inhibited_VBN
by_IN
salicylate_NN
treatment_NN
and_CC
highlight_VBP
the_DT
role_NN
of_IN
salicylate_NN
in_IN
the_DT
control_NN
of_IN
gene_NN
expression_NN
of_IN
inflammatory_JJ
mediators_NNS
._.

